# FDA Inspection 542315 - Dilawar Ajani, M.D., P.I. - October 16, 2008

Source: https://www.keypedia.com/records/fda_inspections/dilawar-ajani-md-pi/e1daccfe-1159-450f-aaa7-8de36ee24d6a
Source feed: FDA_Inspections

> FDA Inspection 542315 for Dilawar Ajani, M.D., P.I. on October 16, 2008. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 542315
- Company Name: Dilawar Ajani, M.D., P.I.
- Inspection Date: 2008-10-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1257425 - 2024-12-16](https://www.keypedia.com/records/fda_inspections/dilawar-ajani-md-pi/849c27b3-4f71-42d7-99de-ca8df74f204d)
- [FDA Inspection 1257425 - 2024-12-16](https://www.keypedia.com/records/fda_inspections/dilawar-ajani-md-pi/0e054ac2-ca41-450e-9ae4-a009f14e64ac)
- [FDA Inspection 1020814 - 2017-07-17](https://www.keypedia.com/records/fda_inspections/dilawar-ajani-md-pi/75d3f726-4421-4171-bf8b-a2f65397e7de)

Company: https://www.keypedia.com/companies/dilawar-ajani-md-pi/a28e4f2b-94f3-47c3-8695-01c6065289f7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c